Subnormal energy expenditure: A putative causal factor in the weight gain induced by treatment of hyperthyroidism

Diabetes, Obesity and Metabolism

Volumn 8, Issue 2, 2006, Pages 220-227

  Jacobsen, R ^a   Lundsgaard, C ^b   Lorenzen, J ^a   Toubro, S ^a   Perrild, H ^b   Krog Mikkelsen, I ^a   Astrup, Arne ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

Energy expenditure; Hyperthyroidism; Spontaneous physical activity; Substrate oxidation; Thyroid hormones

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; LIOTHYRONINE; PROPRANOLOL; RADIOACTIVE IODINE; THIAMAZOLE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; AGED; ARTICLE; BODY COMPOSITION; BODY MASS; BODY WEIGHT DISORDER; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLING; ENERGY EXPENDITURE; FEMALE; FOLLOW UP; HEART RATE; HORMONE INHIBITION; HUMAN; HYPERTHYROIDISM; LIOTHYRONINE BLOOD LEVEL; MALE; MULTIPLE REGRESSION; PHYSICAL ACTIVITY; RESPIRATORY QUOTIENT; THYROID HORMONE BLOOD LEVEL; THYROXINE BLOOD LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE; WEIGHT GAIN;

EID: 33646015346     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2005.00486.x     Document Type: Article

References (24)

1. Astrup A, Buemann B, Christensen NJ et al. The contribution of body composition, substrates, and hormones to the variability in energy expenditure and substrate utilization in premenopausal women. J Clin Endocrinol Metab 1992; 74: 279-286.
2. Toubro S, Sorensen TI, Ronn B, Christensen NJ, Astrup A. Twenty-four-hour energy expenditure: The role of body composition, thyroid status, sympathetic activity, and family membership. J Clin Endocrinol Metab 1996; 81 (7): 2670-2674.
3. Hoogwerf BJ & Nuttall FQ. Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am J Med 1984; 76: 963-970.
4. Lönn L, Stenlöf K, Ottosson M, Lindroos AK, Nyström E, Sjöström L. Body weight and body composition changes after treatment of hyperthyroidism. J Clin Endocrinol Metab 1998; 83: 4269-4273.
5. Crooks J, Murray IPC, Wayne EJ. Statistical methods applied to the clinical diagnosis of thyrotoxicosis. Q J Med 1959; 28: 211-234.
6. Berg G, Michanek A, Holmberg E, Nyström E. Clinical outcome of radioiodine treatment of hyperthyroidism: A follow-up study. J Intern Med 1996; 239: 165-171.
7. Jansson S, Berg G, Lindstedt G, Michanek A, Nyström E. Overweight - a common problem among women treated for hyperthyroidism. Postgrad Med J 1993; 69: 107-111.
8. Dale J, Daykin J, Holder R, Sheppard MC, Franklyn JA. Weight gain following treatment of hyperthyroidism. Clin Endocrinol 2001; 55: 233-239.
9. Franklyn JA, Daykin J, Drolc Z, Farmer M, Sheppard MC. Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) 1991; 34 (1): 71-76.
10. Child DF, Mughi MASS, Hudson P, Williams CP, Harvey JN. Hyperthyroidism and radio-iodine therapy in a district general hospital. J R Soc Med 1994; 87: 578-580.
11. Tigas S, Idiculla J, Beckett G, Toft A. Is excessive weight gain after ablative treatment of hyperthyroidism due to inadequate thyroid hormone therapy? Thyroid 2000; 10 (12): 1107-1111.
12. Pears J, Jung RT, Gunn A. Long-term weight changes in treated hyperthyroid and hypothyroid patients. Scott Med J 1990; 35 (6): 180-182.
13. Astrup A, Thorbek G, Lind J, Isaksson B. Prediction of 24h energy expenditure and its components from physical characteristics and body composition in normal-weight humans. Am J Clin Nutr 1990; 52: 777-783.
14. Heitmann BL. Prediction of body water and fat in adult Danes from measurement of electrical impedance. A validation study. Int J Obes 1990; 14: 789-802.
15. Flint A, Raben A, Rehfeld JF, Holst JJ, Astrup A. The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans. Int J Obes Relat Metab Disord 2000; 24: 288-298.
16. Klausen B, Toubro S, Astrup A. Age and sex effects on energy expenditure. Am J Clin Nutr 1997; 65: 895-907.
17. Abid M, Billington CJ, Nuttal FQ. Thyroid function and energy intake during weight gain following treatment of hyperthyroidism. J Am Coll Nutr 1999; 18 (2): 189-193.
18. Riis AL, Hansen TK, Moller N, Weeke J, Jorgensen JO. Hyperthyroidism is associated with suppressed circulating ghrelin levels. J Clin Endocrinol Metab 2003; 88 (2): 853-857.
19. Pijl H, de Meijer PH, Langius J et al. Food choice in hyperthyroidism: potential influence of the autonomic nervous system and brain serotonin precursor availability. J Clin Endocrinol Metab 2001; 86 (12): 5848-5853.
20. Zimmermann-Belsing T, Dreyer M, Holst JJ, Feldt-Rasmussen U. The relationship between the serum leptin concentrations of thyrotoxic patients during treatment and their total fat mass is different from that of normal subjects. Clin Endocrinol 1998; 49: 589-595.
21. Bayley TA, Harrison JE, McNeill KG, Mernagh JR. Effect of thyrotoxicosis and its treatment on bone mineral and muscle mass. J Clin Endocrinol Metab 1980; 50: 916-922.
22. De La Rosa RE, Hennessey JV, Tucci JR. A longitudinal study of changes in body mass index and total body composition after radioiodine treatment for thyrotoxicosis. Thyroid 1997; 7 (3): 401-405.
23. Kyle UG, Bosaeus I, De Lorenzo AD et al. Composition of the ESPEN Working Group. Bioelectrical impedance analysis-part I: Review of principles and methods. Clin Nutr 2004; 23 (5): 1226-1243.
24. Weyer C, Snitker S, Rising R, Bogardus C, Ravussin E. Determinants of energy expenditure and fuel utilization in man: Effects of body composition, age, sex, ethnicity and glucose tolerance in 916 subjects. Int J Obes Relat Metab Disord 1999; 23 (7): 715-722.